Digital Health Roundup: HIMSS, Cardio Conversations, ChatGPT And New FDA Guidances

In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb discusses how two medtech CEOs are and aren’t using ChatGPT in their businesses while Reed Miller talks about his “Cardio Conversations” podcast interviews with Quentin Blackford, CEO of iRhythm and Rob Krummen, CEO of Vektor Medical. Washington, DC-based reporter Hannah Daniel reviews highlights from the HIMSS conference and the latest updates on FDA guidances. Listen to the podcast via the player below: Medtech Insight articles addressing topics discussed in this episode: Cardio Conversations: iRhythm Prepares To Deliver ‘Standard-Of-Care’ Cardiac Monitoring Cardio Conversations: Vektor Addresses ‘Global Health Crisis’ With Arrythmia Mapping HIMSS23 Using The Metaverse To Break Down Language Barriers and Improve Diversity In Clinical Trials Tales From HIMSS23: FDA On FHIR And AI For The Voiceless Decentralized Clinical Trial Guidance Fulfills Promise, Underlies Digitization Of Healthcare Expert: FDA’s Highly Anticipated PCCP Guidance Isn’t Anything Too ‘Surprising’ How Two Medtech CEOs Are (And Aren’t) Using ChatGPT In Their Businesses